When the pharmaceutical company has many suppliers, then these suppliers should also be assessed by classifying them into distinct ranges dependent on their effect on the medicinal product.="" in="" accordance="" with="" the="" regulatory="" flexibility="" act,="" fda="" has="" regarded as="" the="" impact="" of="" this="" motion="" on="" small=""